Dr Reddys Laboratories Ltd Share Price Today, Live NSE/BSE Updates

NSEBSE

There is a 15-minute delay in the prices. To check out the live prices, log in to your Ventura account or open one today.

Max

Open-

High-

Low-

Prev. Close-

Avg. Traded Price-

Volume-

MARKET DEPTH

Total bid0.00

Total ask0.00

Orders	Qty	Bid

Ask	Qty	Orders

HIGH/LOW

52w

LOW/HIGH

₹1,345.00a day ago

₹1,366.80a day ago

LOWER/UPPER CIRCUITS

₹1,226.50

₹1,498.90

Dr Reddys Laboratories Ltd Stock performance

KEY OBSERVATIONS

positive

negative

neutral

Annual Revenue,rose 16.73%, in the last year to ₹33,741.2 Cr. Its sector's average revenue growth for the last fiscal year was 10.81%.

Annual Net Profit,rose 1.38% in the last year to ₹5,655.1 Cr. Its sector's average net profit growth for the last fiscal year was 38.61%.

Price to Earning Ratio,is 20.11, lower than its sector PE ratio of 41.74.

LONG-TERM PRICE ANALYSIS

Stock return5Y CAGR : 17.24%

Net profit growth 5Y CAGR : 23.89%

STOCK RETURNS

Versus Nifty 50

1 w

+4.69%

+1.58%

1 mth

+13.01%

+0.87%

3 mth

+22.25%

+11.89%

6 mth

+8.49%

+2.41%

1 yr

+11.48%

+7.8%

3 yr

+55.24%

+55.18%

5 yr

+68.55%

+152.1%

Dr Reddys Laboratories Ltd Top mutual funds holding

Bank of India Mfg & Infra Fund-Reg(G)

3Y Return+29.9%

NAV₹55.91

ICICI Pru Pharma Healthcare & Diagnostics (P.H.D) Fund-(G)

3Y Return+29.8%

NAV₹39.37

Similar stocks

SUNPHARMA₹1,687.80+0.40 (0.02%)

DIVISLAB₹6,667.00-58.00 (0.86%)

CIPLA₹1,505.20+2.40 (0.16%)

TORNTPHARM₹3,252.50-6.30 (0.19%)

MANKIND₹2,381.30-8.70 (0.36%)

Dr. Reddy’s Laboratories Limited commenced its generics business in India in 1986 and is currently a trusted name in the healthcare industry consistently serving the needs of millions of patients with high quality, affordable and innovative medicines across therapy areas. The company is a leading India-based pharmaceutical company headquartered and having its registered office in Hyderabad, Telangana, India. Through its three businesses - Pharmaceutical Services and Active Ingredients, Global Generics and Proprietary Products - the Company offers a portfolio of products and services, including Active Pharmaceutical Ingredients (APIs), Custom Pharmaceutical Services (CPS), generics, biosimilars and differentiated formulations.

Grow your wealth with more research recommendations

+91

We're all set for a new experience. To visit the old Ventura website, click here.

Ventura Wealth Clients Login here